glyn

GLYN, a nitric oxide donor, acts by enhancing the therapeutic efficacy of chemotherapy and radiotherapy.

Argipressin, des-glynh2(9)-, can effect on aggregation of blood platelets.

Saroglitazar (Lipaglyn) is an agonist of PPAR with EC50 values of 0.65 pM and 3 nM for PPARα and PPARγ.

Fmoc-Gly-Gly-Gly-NH-PEG4-C2-COOH is a type of PROTAC linker classified under the PEG category. Benzyl-PEG6-Ots is suitable for synthesizing PROTAC molecules.

R 396 (Acleu-asp-gln-trp-phe-glynh2) is a linear hexapeptide and is also an NK-2 tachykinin receptor antagonist.

Felypressin (Octapressin) is a synthetic analog of LYPRESSIN with a PHENYLALANINE substitution at residue 2. Felypressin is a vasoconstrictor with reduced antidiuretic activity.

Felypressin acetate (PLV-2) is an agonist of vasopressin 1 and acts on all arginine vasopressin receptors 1AS. Felypressin acetate can be used in dental procedures.

Polyglyceryl-10 stearate is a biochemical.

MC-Gly-Gly-Phe-Gly-NH-CH2-O-CH2COOH is a degradable ADC linker used for synthesizing ADCs (antibody-drug conjugates).

H-Gly-Pro-Gly-NH2, a tripeptide, effectively inhibits HIV-1 replication by interfering with capsid formation, demonstrating antiviral activity particularly against HIV-1 III B and HIV-2 ROD with EC 50 values of 35 µM and 30 µM, respectively. This compound's ability to disrupt the viral replication process positions it as a valuable asset for virus research [1] [2] [3].

(D(CH2)51,Tyr(Me)2,Thr4,Orn8,des-Gly-NH29)-Vasotocin, serving as an oxytocin receptor antagonist, effectively nullifies the augmentation of inhibitory postsynaptic currents in CA1 pyramidal neurons by oxytocin [1].

Fmoc-Gly-NH-CH2-O-CH2COOH is an ADC linker used in the synthesis of antibody-drug conjugates (ADCs) [1].

Fmoc-Gly-NH-CH2-acetyloxy serves as a cleavable linker for the synthesis of antibody-drug conjugates (ADCs).

Gly-Gly-Phe-Gly-NH-CH2-O-CH2COOH is an ADC linker used in synthesizing drug-linker conjugates for ADCs, particularly for the creation of Deruxtecan, a potent drug-linker conjugate [1].

r8-Gly-Noxa A BH3 is a biologically active, cell-permeable peptide comprising amino acid residues 17 to 36 from the BH3 (death) domain of Noxa A, modified by eight D-Arginine residues and a Glycine linker at its amino terminus.

pGlu-His-Pro-Gly-NH2, also known as Glp-His-Pro-Gly-NH2, is a tetrapeptide that promotes the release of gonadotropin, luteinizing hormone (LH), and follicle-stimulating hormone (FSH) [1] [2].

Cyclooctyne-O-amido-PEG4-VC-PAB-Gly-Gly-NH-O-CO-Exatecan is a drug-linker conjugate utilized in Antibody-Drug Conjugates (ADC Cytotoxin: Exatecan) [1].

Fmoc-Gly-NH-CH2-O-(S)-isobutane-Cbz serves as an intermediate in the synthesis of ADC Linkers, which are essential for connecting specific antibodies to cytotoxic molecules [1].

MC-Gly-Gly-Phe-Gly-NH-CH2-O-cyclopropane-CH2COOH, a derivative of camptothecin, is utilized in the development of antibody drug conjugates (ADC) [1].

Pro-Leu-Gly-NHOH hydrochloride functions as an MMP-8 inhibitor [1].

Gly-Gly-Phe-Gly-NH-O-CO-Exatecan is a drug-linker conjugate that integrates the linker Gly-Gly-Phe-Gly-NH-O-CO with Exatecan. This compound is essential for the formulation of antibody conjugate drugs. Exatecan acts as a DNA topoisomerase I inhibitor, which is utilized in cancer research [1] [2].

Gly-NH-CH2-Boc, a cleavable ADC linker, is utilized in synthesizing antibody-conjugated active molecules (ADC) [1].

MC-Gly-Gly-{D-Phe}-Gly-NH-CH2-O-CH2COOH is a cleavable ADC linker employed in the production of antibody-drug conjugates (ADCs) [1].

Fmoc-Gly-NH-CH2-O-Cyclopropane-CH2COOH serves as an intermediate for ADC linker synthesis. This linker, which includes Benzyl 2-cyclopropyl-2-hydroxyacetate, is capable of being coupled to Exatecan and subsequently linked with antibodies (such as antibody hu2F7) [1].